Key highlights
- 1The Japan high-purity water systems market is expected to reach USD 3.2 billion by 2036, at a CAGR of 8.6% from 2026 to 2036, driven by semiconductor fab investment, pharmaceutical water demand, and water reuse requirements.
- 2Semiconductors lead demand. The semiconductor industry is the largest consumer of ultrapure water, and an average fab uses about 2 to 10 million gallons of ultrapure water per day, making high-purity water systems critical infrastructure for chipmaking.
- 3Fab buildout drives investment. TSMC's roughly USD 23 billion Kumamoto fab began production in December 2024, and Rapidus is building a 2-nanometre fab in Chitose, Hokkaido, chosen partly for abundant water, with a pilot line from April 2025 and mass production targeted for 2027.
- 4Japanese suppliers are global leaders. Kurita Water Industries, Organo Corporation and Nomura Micro Science are among the world's leading ultrapure water equipment companies, with Nomura Micro Science reporting orders up about 55.9% and Organo a key supplier to TSMC.
- 5Water reuse is a priority. Water recycling and recovery loops can reduce fab water intake by up to about 85%, and stricter discharge standards and sustainability targets are driving minimum- and zero-liquid-discharge strategies.
- 6Membrane pharmaceutical water is growing. Since 2017 the Japanese Pharmacopoeia has accepted membrane-based water for injection, and membrane systems can cut capital cost by up to about 70% and operating cost by up to about 90% versus distillation.
- 7Key companies include Kurita Water Industries, Ltd., Organo Corporation, Nomura Micro Science Co., Ltd., Toray Industries, Inc., and Nitto Denko Corporation.
Report Overview
The Japan high-purity water systems market covers the equipment, services and consumables that produce ultrapure and high-purity water, spanning reverse osmosis, electrodeionization, ion exchange, ultrafiltration, ultraviolet oxidation and distillation, for semiconductor and electronics manufacturing, pharmaceuticals and biotechnology, power generation, and laboratory and research use. Municipal and general industrial water treatment outside high-purity applications is not the focus. The market is capital-intensive and technically demanding, with recurring services and consumables such as membranes and resins, and is led by the semiconductor industry. Demand is shaped by fab investment, pharmaceutical water standards, and water reuse and sustainability. This report examines the size, drivers, water types, technologies, end-use industries, offerings, pricing, regional demand clusters, competition, recent developments, and outlook of the market, and provides recommendations. Sizing is built bottom-up from semiconductor ultrapure water systems, pharmaceutical and biotechnology water, power and industrial use, and services and consumables, and reflects high-purity water systems used in Japan.
Market dynamics
Drivers
- 01Semiconductor fab investment is the primary driver as ultrapure water is essential to wafer cleaning and the semiconductor industry is the largest consumer of ultrapure water, with an average fab using about 2 to 10 million gallons per day; TSMC's roughly USD 23 billion Kumamoto fab began production in December 2024, and Rapidus is building a 2-nanometre fab in Chitose, Hokkaido, with government support from METI lifting total public backing into the trillions of yen.
- 02Pharmaceutical water requirements are a driver as purified water and water for injection are needed for drug and biologics manufacturing, and since 2017 the Japanese Pharmacopoeia has accepted membrane-based water for injection, which lowers capital and operating cost.
- 03Water reuse and sustainability pressure is a driver as recycling loops can cut fab water intake by up to about 85%, and stricter discharge standards and sustainability targets push minimum- and zero-liquid-discharge systems.
Opportunities
- 01Semiconductor ultrapure water systems are the leading opportunity because the buildout of fabs by TSMC, Rapidus, Micron, Kioxia and others requires large ultrapure water plants and ongoing service, and Japanese suppliers such as Kurita, Organo and Nomura Micro Science are well positioned.
- 02Water reuse and zero-liquid-discharge are an opportunity as reuse cuts intake and cost and meets sustainability and discharge requirements, and advanced fabs pursue high recovery.
- 03Membrane pharmaceutical water is an opportunity as Japanese acceptance of membrane water for injection since 2017 shifts pharmaceutical water toward reverse osmosis and ultrafiltration systems at lower cost than distillation.
Trends
- 01The fab-driven demand surge is the defining trend reflected in strong order growth, with Nomura Micro Science reporting orders up about 55.9% and Organo's prominence as a TSMC supplier.
- 02Water reuse and zero-liquid-discharge are a structural trend as fabs pursue high recovery and reuse to reduce intake, cost and discharge.
- 03Membrane water for injection is a trend in pharmaceuticals as Japanese acceptance since 2017 moves water for injection from distillation to membrane systems.
- 04Tighter purity for advanced nodes is a technical trend as 2-nanometre and other leading-edge processes demand ever-lower contaminant levels in ultrapure water.
Report Summary
| Base Year | 2025 |
|---|---|
| Forecast Period | 2026-2036 |
| Market Size (2025) | USD 1.3 billion |
| Market Size (2026) | USD 1.41 billion |
| Market Size (2036) | USD 3.2 billion |
| CAGR (Value) | 8.6% (2026-2036) |
| Format | PDF & Excel |
| Segments Covered | By Water Type: Ultrapure Water, Purified / High-Purity Water, Deionized Water. By Technology:Reverse Osmosis, Electrodeionization, Ion Exchange, Ultrafiltration, UV / Others. By End-Use Industry; By Offering. |
| Geographies Covered | Japan (Kyushu, Hokkaido, and other fab and industrial clusters) |
| Key Companies | Kurita Water Industries, Ltd., Organo Corporation, Nomura Micro Science Co., Ltd., Miura Co., Ltd., Toray Industries, Inc., Nitto Denko Corporation, Mitsubishi Chemical Corporation, DuPont Water Solutions, Veolia Water Technologies, Ovivo (SKion Water), Other Companies |
Segmental analysis
By Water Type
- Ultrapure water holds the largest share at about 60% of the market in 2026, with the remaining share divided across purified and high-purity water and deionized water.
- Ultrapure water purified to a resistivity of 18.2 megaohm-centimetres with very low total organic carbon, particles and bacteria, is the largest type because it is essential to semiconductor manufacturing, the largest ultrapure water application, where wafers are cleaned and rinsed with water of extreme purity.
- Purified and high-purity water including pharmaceutical purified water and water for injection, is a substantial type used in drug and biologics manufacturing.
- Deionized water serves power generation laboratories and general high-purity industrial uses.
The dominance of ultrapure water reflects the scale and stringency of semiconductor demand.
By Technology
- Reverse osmosis holds the largest share at about 35% of the market in 2026, with the remaining share divided across electrodeionization, ion exchange, ultrafiltration, ultraviolet oxidation and other technologies.
- Reverse osmosis is the largest technology because it is the core desalting and purification step in ultrapure and high-purity water production, with single-pass recovery of about 70 to 85% , and Japan hosts leading membrane makers.
- Electrodeionization provides continuous chemical-free polishing.
- Ion exchange removes remaining ions and is used with continuous regeneration.
- Ultrafiltration removes fine particles and is used in final polishing and membrane water for injection.
- Ultraviolet oxidation reduces total organic carbon and distillation remains used in some pharmaceutical water.
The prominence of reverse osmosis reflects its central role and the country's membrane strength, and systems combine multiple technologies in multi-stage trains.
By End-Use Industry
- Semiconductor and electronics holds the largest share at about 55% of the market in 2026, with the remaining share divided across pharmaceuticals and biotechnology, power generation, laboratory and research, food and beverage, and others.
- Semiconductor and electronics is the leading end-use industry because ultrapure water is critical to chipmaking, fabs consume the most high-purity water, and Japan is investing heavily in fabs such as TSMC Kumamoto and Rapidus in Hokkaido.
- Pharmaceuticals and biotechnology use purified water and water for injection.
- Power generation uses high-purity water for boilers and cooling.
- Laboratory and research and food and beverage use high-purity water in smaller volumes.
The dominance of semiconductor and electronics reflects the scale of ultrapure water demand in chip manufacturing.
By Offering
- Equipment and systems the capital plant for producing ultrapure and high-purity water, hold the largest share, driven by fab and facility construction.
- Services including engineering, operation, maintenance and water management, are a large and recurring offering, important to fabs that require reliable ultrapure water supply.
- Consumables including reverse osmosis membranes, ion exchange resins, ultrafiltration modules and ultraviolet lamps, are a recurring offering tied to the installed base.
The balance of capital equipment during fab buildout and recurring services and consumables over the life of systems shapes the offering mix, with services and consumables providing steady revenue between capital cycles.
Geographic analysis
Kyushu Region (Kumamoto)
Kyushu and Kumamoto in particular, has become a major semiconductor cluster, anchored by TSMC's roughly USD 23 billion fab through Japan Advanced Semiconductor Manufacturing, which began production in December 2024, alongside Sony and suppliers. The concentration of advanced fabs makes Kyushu a leading regional market for ultrapure water systems and services, and the region illustrates how fab investment drives demand for high-purity water infrastructure and ongoing operation.
Hokkaido Region (Chitose)
Hokkaido and Chitose in particular, hosts Rapidus's 2-nanometre fab, chosen partly for its abundant water, cool climate and renewable-energy potential, with a pilot line from April 2025 and mass production targeted for 2027, supported by substantial METI funding. The region is an emerging major market for ultrapure water systems, and the abundance of water in Chitose underlines the importance of water availability to fab siting and the scale of high-purity water demand at leading-edge nodes.
Other Regions and National Demand
Other regions host significant demand including Hiroshima and the Chugoku region with Micron, Mie Prefecture with Kioxia, and the Tohoku and Kanto regions with electronics, pharmaceutical and research facilities. National demand combines semiconductor fabs, pharmaceutical manufacturing and power and industrial users, and is served by Japan's leading ultrapure water suppliers. The distribution of fabs and pharmaceutical plants across regions shapes where high-purity water systems and services are needed.
Pricing Analysis
Pricing in high-purity water systems reflects capital scale, purity requirements, and recurring services and consumables. Ultrapure water systems for advanced fabs are large capital projects, priced on capacity, purity specification and engineering complexity, and leading-edge nodes that demand the highest purity carry the most stringent and costly requirements. Pharmaceutical water systems are priced on validation, quality and regulatory compliance, and membrane water for injection can lower capital and operating cost, by up to about 70% and 90% respectively, relative to distillation. Several factors set price. Capacity and purity are central, as larger, higher-purity systems cost more, and semiconductor ultrapure water plants are among the most demanding. Technology and configuration affect price, with multi-stage trains combining reverse osmosis, electrodeionization, ion exchange and ultrafiltration. Services and consumables are a recurring cost, with membranes, resins and maintenance tied to the installed base. Water reuse and zero-liquid-discharge add capital but reduce water and discharge cost. Regulatory and validation requirements raise pharmaceutical system cost.
The trajectory of pricing depends on fab investment, advancing purity requirements, and the balance of capital projects against recurring services and consumables, and the market combines large capital cycles with steady service and consumable revenue.
Competitive landscape
The market is led by Japanese ultrapure water specialists, membrane and resin makers, and global suppliers. Kurita Water Industries, Ltd. is a leading water treatment company with a large electronics and ultrapure water business serving semiconductor fabs. Organo Corporation is a major ultrapure water supplier and a key supplier to TSMC, and Nomura Micro Science Co., Ltd. specialises in ultrapure water for semiconductor manufacturing, with strong order growth and customers including major chipmakers. Toray Industries, Inc. and Nitto Denko Corporation, through Hydranautics, are leading reverse osmosis membrane makers, and Mitsubishi Chemical Corporation supplies ion exchange resins, giving Japan strength across the value chain. Miura Co., Ltd. supplies pharmaceutical and industrial water systems, and global suppliers DuPont Water Solutions, Veolia Water Technologies and Ovivo, part of SKion Water, compete in equipment and membranes.
Competition turns on technology and purity capability, engineering and project delivery, service and reliability, and membrane and consumable performance, and Japan is unusual in hosting several of the world's leading ultrapure water companies and membrane makers. The semiconductor buildout, water reuse requirements and advancing purity favour suppliers that can deliver reliable, high-recovery ultrapure water systems and ongoing service, and Kurita, Organo and Nomura Micro Science hold strong positions, supported by Toray and Nitto Denko in membranes. The field is competitive and technically advanced, and demand is driven by the fab investment cycle and recurring service and consumable needs.
Voice of Customer
Ultrapure water is critical infrastructure for our fab; any interruption or purity excursion stops production, so we invest in reliable systems and service. As we move to more advanced nodes the purity requirements tighten, and water reuse is now essential both for cost and for meeting discharge and sustainability targets, so we work closely with our ultrapure water suppliers on recovery and reliability.
Facilities engineer, semiconductor fab (Japan):
For purified water and water for injection, compliance and reliability are paramount, and the acceptance of membrane-based water for injection has let us consider systems with lower capital and operating cost than distillation. Validation and quality are non-negotiable, and we value suppliers who understand pharmaceutical requirements and provide dependable service.
Utilities manager, pharmaceutical plant (Japan):
The fab buildout has driven strong demand for ultrapure water systems, and delivery capacity and engineering are the constraints. Customers want high recovery and reuse, integrated multi-stage systems, and reliable long-term service, and the leading Japanese ultrapure water companies and membrane makers give us strong local capability.
Project lead, engineering contractor (Japan):
Analyst perspective
Japan's high-purity water systems market is a technically advanced, capital-intensive market driven by the country's semiconductor revival and supported by a world-leading domestic supply base. The core demand comes from semiconductors, the largest consumer of ultrapure water, where fabs use millions of gallons per day and purity is critical; the buildout of TSMC's Kumamoto fab, which began production in December 2024, and Rapidus's 2-nanometre fab in Chitose, targeted for mass production in 2027, with major METI support, are driving large ultrapure water investment. Japan is unusual in hosting several of the world's leading ultrapure water companies, Kurita, Organo and Nomura Micro Science, and leading membrane and resin makers in Toray, Nitto Denko and Mitsubishi Chemical, giving it strength across the value chain. Pharmaceutical water and water reuse add further demand.
The honest considerations are cyclicality, cost, and execution. High-purity water demand is tied to the semiconductor capital cycle, which is subject to swings, so growth depends on the pace and completion of fab investment, and projects such as Rapidus carry execution and commercial risk despite strong government backing. Systems are capital-intensive and technically demanding, and water and energy intensity, discharge standards and skilled maintenance are real constraints, which is why water reuse and zero-liquid-discharge are central. The market should be assessed on fab investment, the balance of capital projects and recurring services and consumables, and progress on water reuse and advancing purity, and Japan's strong fab pipeline and world-leading supply base support solid growth, with recurring service and consumable revenue providing stability across the capital cycle.
Strategic Recommendations
For system suppliers
The priority is to expand capacity and service capability for semiconductor ultrapure water and to lead on water reuse, because demand is driven by the fab buildout and shaped by sustainability, and reliability, high recovery and service are what customers require. Companies should invest in engineering and delivery capacity to meet fab demand, develop high-recovery and zero-liquid-discharge systems, strengthen recurring service and consumable offerings, and advance purity capability for leading-edge nodes. Leveraging Japan's strength in membranes and resins and building long-term relationships with fabs and pharmaceutical plants strengthen the market position.
For semiconductor and pharmaceutical customers
The recommendation is to secure reliable, high-recovery high-purity water systems and long-term service, given the criticality of ultrapure water and the cost and sustainability benefits of reuse, and to adopt membrane water for injection where it lowers cost. For engineering contractors, capacity and integration capability are the constraints to address. For policymakers, support for the semiconductor industry, water infrastructure and sustainability underpins the market and the fabs it serves. For investors, this is a technically advanced market tied to the semiconductor capital cycle, to evaluate on fab investment, the balance of capital and recurring revenue, and water reuse and purity leadership, recognising that Japan's strong fab pipeline and world-leading ultrapure water and membrane suppliers support solid growth, while cyclicality and execution are the key risks.
Sustainability impact
Water Reuse and Recovery
High-purity water systems increasingly incorporate reuse and recovery, reducing the large water intake of fabs and industrial plants. High-purity water systems support water conservation.
By recovering and reusing water, with reuse loops able to cut fab intake by up to about 85%, high-purity water systems reduce freshwater withdrawal in water-intensive semiconductor and industrial manufacturing, easing pressure on local water resources.
Zero-Liquid-Discharge and Effluent Control
Minimum- and zero-liquid-discharge systems reduce wastewater discharge and help meet stricter environmental standards.High-purity water systems support discharge reduction.
By concentrating and treating effluent toward minimum- or zero-liquid-discharge, high-purity water systems reduce the volume and improve the quality of wastewater from fabs and plants, helping meet tightening discharge standards and protecting receiving waters.
Energy and Resource Efficiency
Membrane technologies such as reverse osmosis and membrane water for injection reduce the energy and resource use of high-purity water production versus older methods. High-purity water systems support energy efficiency.
By using membrane processes rather than energy-intensive distillation where suitable, high-purity water systems reduce energy and operating cost, with membrane water for injection cutting operating cost by up to about 90%, improving the resource efficiency of pharmaceutical and industrial water.
Enabling Critical Industries Responsibly
High-purity water systems enable semiconductor and pharmaceutical manufacturing while managing their water footprint.High-purity water systems support responsible manufacturing.
By providing the ultrapure and high-purity water that chipmaking and medicine production require, together with reuse and discharge control, high-purity water systems enable critical industries to operate while limiting their water and environmental footprint.
Table of contents
15 chapters · 130 pages · click to expandFrequently asked questions
The Japan high-purity water systems market was valued at USD 1.3 billion in 2025 and is projected to reach USD 3.2 billion by 2036, growing from USD 1.41 billion in 2026, at a CAGR of 8.6% from 2026 to 2036, driven by semiconductor fab investment, pharmaceutical water demand, and water reuse.